In response to: Heise T, N?rskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes. Diabetes Obes Metab Diabetes Obes Metab . 2017;19:1032–1039

Becker Reinhard H.A.

首页> 外文期刊>Diabetes, obesity & metabolism >In response to: Heise T, N?rskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes. Diabetes Obes Metab Diabetes Obes Metab . 2017;19:1032–1039

【24h】

In response to: Heise T, N?rskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes. Diabetes Obes Metab Diabetes Obes Metab . 2017;19:1032–1039

机译：响应：Heise T，N？Rskov M，Nosek L，Kaplan K，Famulla S和Haahr HL（2017）胰岛素Degludec：与类型的胰岛素龟头U300相比，药效学反应的日常日期和日期内变异性 1糖尿病。糖尿病互补糖尿病obes metab。 2017; 19：1032-1039

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes, obesity & metabolism》 |2018年第8期|共5页
作者
Becker Reinhard H.A.;
展开▼
作者单位

Wiesbaden/BerlinGermany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献

1. In response to: Heise T, N?rskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes. Diabetes Obes Metab Diabetes Obes Metab . 2017;19:1032–1039 [J] . Becker Reinhard H.A. Diabetes, obesity & metabolism . 2018,第8期

机译：响应：Heise T，N？Rskov M，Nosek L，Kaplan K，Famulla S和Haahr HL（2017）胰岛素Degludec：与类型的胰岛素龟头U300相比，药效学反应的日常日期和日期内变异性 1糖尿病。糖尿病互补糖尿病obes metab。 2017; 19：1032-1039
2. Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2) [J] . Hiroshi Miura, Kazuhiko Sakaguchi, Yuko Okada, Diabetes therapy . 2018,第6期

机译：胰岛素Degludec和甘精胰岛素U300对1型糖尿病患者日常空腹血浆葡萄糖变异性的影响：一项多中心，随机，交叉研究（Kobe Best Basal Insulin Study 2）
3. Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study [J] . Tomoaki Nakamura, Kazuhiko Sakaguchi, Anna So, Diabetologia: clinical and experimental diabetes and metabolism . 2015,第9期

机译：地格曲胰岛素和甘精胰岛素对1型糖尿病患者每日空腹血浆葡萄糖变异性的影响：一项多中心，随机，交叉研究
4. Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes [O] . Tim Heise, Marianne Nørskov, Leszek Nosek, -1

机译：地格曲胰岛素：与1型糖尿病的甘精胰岛素300 / U / mL相比药效学响应的每日和当日差异较低
5. Morning administration of 0.4 U/kg/day insulin glargine 300 U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100 U/mL in type 1 diabetes [O] . T.S. Bailey, J. Pettus, R. Roussel, 2018

机译：早晨给药0.4U / kg /天胰岛素冰柱300 u / ml提供较少的24小时药效动动力学和更均匀的药代动力学曲线，与1型糖尿病中的胰岛素Degludec 100u / ml相比

In response to: Heise T, N?rskov M, Nosek L, Kaplan K, Famulla S and Haahr H. L. (2017) Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared to insulin glargine U300 in type 1 diabetes. Diabetes Obes Metab Diabetes Obes Metab . 2017;19:1032–1039

著录项

相似文献

相关主题

期刊订阅